U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07419074) titled 'Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients' on Feb. 11.
Brief Summary: Garcinia cambogia, rich in hydroxycitric acid (HCA), has been suggested to promote weight loss and improve metabolic parameters. Evidence regarding its efficacy in pre-diabetic obese adults remains limited.
Objective: To evaluate the effects of Garcinia cambogia rind powder supplementation on anthropometric, glycemic, lipid, hepatic, and renal parameters in pre-diabetic obese adults.
Study Start Date: Sept. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Lipid Profile
Interve...